GOLDMAN SACHS GROUP INC

Holdings History for LIFECORE BIOMEDICAL, INC. DE - COM (LFCR)

Symbol: LFCR on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0%	+0%	$290K	58.9K	+20,038	+51.5%	$4.93	Q3 2024
6/30/2024	0%	0%	$199K	38.9K	-48,825	-55.7%	$5.13	Q2 2024
3/31/2024	0%	+0%	$466K	87.7K	+54,106	+161%	$5.31	Q1 2024
12/31/2023	0%	+0%	$208K	33.6K	+22,558	+204%	$6.19	Q4 2023
9/30/2023	0%	0%	$83.3K	11K	-34,199	-75.6%	$7.54	Q3 2023
6/30/2023	0%	0%	$437K	45.2K	-29,564	-39.5%	$9.67	Q2 2023
3/31/2023	0%	+0%	$282K	74.8K	+6,422	+9.39%	$3.78	Q1 2023
12/31/2022	0%	0%	$443K	68.4K	-13,539	-16.5%	$6.48	Q4 2022
9/30/2022	0%	+0%	$728K	81.9K	+3,139	+3.98%	$8.89	Q3 2022
6/30/2022	0%	0%	$785K	78.8K	-9,288	-10.5%	$9.96	Q2 2022
3/31/2022	0%	0%	$1.02M	88.1K	-9,709	-9.93%	$11.58	Q1 2022
12/31/2021	0%	+0%	$1.09M	97.8K	+61,148	+167%	$11.10	Q4 2021
9/30/2021	0%	0%	$338K	36.6K	-56,102	-60.5%	$9.23	Q3 2021
6/30/2021	0%	0%	$1.04M	92.7K	-51,706	-35.8%	$11.25	Q2 2021
3/31/2021	0%	0%	$1.53M	144K	-103,150	-41.7%	$10.60	Q1 2021
12/31/2020	0%	+0%	$2.69M	248K	+39,528	+19%	$10.85	Q4 2020
9/30/2020	0%	+0%	$2.02M	208K	+8,219	+4.11%	$9.72	Q3 2020
6/30/2020	0%	+0%	$1.59M	200K	+80,705	+67.7%	$7.96	Q2 2020
3/31/2020	0%	+0%	$1.04M	119K	+3,794	+3.29%	$8.69	Q1 2020
12/31/2019	0%	+0%	$1.3M	115K	+48,864	+73.5%	$11.31	Q4 2019
9/30/2019	0%	+0%	$722K	66.5K	+29,584	+80.2%	$10.86	Q3 2019
6/30/2019	0%	0%	$346K	36.9K	-11,025	-23%	$9.38	Q2 2019
3/31/2019	0%	0%	$588K	47.9K	-14,438	-23.2%	$12.27	Q1 2019
12/31/2018	0%	+0%	$738K	62.4K	+4,889	+8.51%	$11.84	Q4 2018
9/30/2018	0%	+0%	$827K	57.5K	+26,982	+88.5%	$14.39	Q3 2018
6/30/2018	0%	0%	$454K	30.5K	-23,272	-43.3%	$14.89	Q2 2018
3/31/2018	0%	0%	$702K	53.8K	-3,104	-5.46%	$13.06	Q1 2018
12/31/2017	0%	0%	$716K	56.9K	-361	-0.63%	$12.59	Q4 2017
9/30/2017	0%	+0%	$741K	57.2K	+4,561	+8.66%	$12.95	Q3 2017
6/30/2017	0%	+0%	$782K	52.7K	+4,594	+9.56%	$14.85	Q2 2017
3/31/2017	0%	+0%	$577K	48.1K	+2,311	+5.05%	$12.00	Q1 2017
12/31/2016	0%	+0%	$631K	45.8K	+4,717	+11.5%	$13.79	Q4 2016
9/30/2016	0%	+0%	$550K	41K	+21,358	+109%	$13.40	Q3 2016
6/30/2016	0%	+0%	$212K	19.7K	+407	+2.11%	$10.77	Q2 2016
3/31/2016	0%	0%	$202K	19.3K	-1,352	-6.56%	$10.48	Q1 2016
12/31/2015	0%	0%	$244K	20.6K	-2,093	-9.21%	$11.83	Q4 2015
9/30/2015	0%	+0%	$265K	22.7K	+7,940	+53.7%	$11.67	Q3 2015
6/30/2015	0%	0%	$213K	14.8K	-6,388	-30.2%	$14.41	Q2 2015
3/31/2015	0%	0%	$295K	21.2K	-4,258	-16.7%	$13.94	Q1 2015
12/31/2014	0%	0%	$351K	25.4K	-3,050	-10.7%	$13.81	Q4 2014
9/30/2014	0%	+0%	$349K	28.5K	+1,264	+4.65%	$12.26	Q3 2014
6/30/2014	0%	0%	$340K	27.2K	-3,900	-12.5%	$12.50	Q2 2014
3/31/2014	0%	0%	$347K	31.1K	-33,953	-52.2%	$11.15	Q1 2014
12/31/2013	0%		$789K	65.1K			$12.13	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.